EUDAMED vs. FDA GUDID: Key Differences Every Medical Device Manufacturer Should Know

For medical device manufacturers selling products internationally, EUDAMED and the FDA Global Unique Device Identification Database (GUDID) are two of the most important regulatory systems for Unique Device Identification (UDI) compliance. Although both support device traceability and patient safety, they serve different regulatory purposes, operate under different authorities, and require different types of regulatory information.

Understanding the differences between EUDAMED and FDA GUDID is essential for companies marketing devices in both the European Union and the United States.

In this guide, we compare the two systems, explain where they overlap, and highlight what manufacturers should consider when building a global UDI compliance strategy.

What Is EUDAMED?

EUDAMED (European Database on Medical Devices) is the European Commission’s centralized database established under the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Medical Device Regulation (IVDR).

Rather than functioning solely as a UDI database, EUDAMED supports multiple aspects of the medical device lifecycle through modules covering:

• Actor Registration
• UDI & Device Registration
• Notified Bodies and Certificates
• Clinical Investigations & Performance Studies
• Vigilance
• Market Surveillance

As of May 2026, several core EUDAMED modules are mandatory for manufacturers operating in the European Union.

What Is FDA GUDID?

The Global Unique Device Identification Database (GUDID) is the U.S. FDA’s database for storing key identification information about medical devices marketed in the United States.

GUDID primarily contains the Device Identifier (DI) portion of the UDI and associated descriptive information. It does not store Production Identifier (PI) values such as lot numbers or serial numbers, although it records which PI attributes apply to a device. Device labelers must submit required device information to GUDID as part of FDA UDI compliance.

EUDAMED vs. FDA GUDID: Side-by-Side Comparison

Similarities Between EUDAMED and FDA GUDID

Although they serve different regulatory frameworks, both systems share several objectives.

Improve Device Traceability

Both databases use Unique Device Identification to improve product traceability throughout the supply chain and healthcare ecosystem.

Enhance Patient Safety

Accurate device identification supports recalls, adverse event investigations, and post-market activities.

Require Structured Regulatory Data

Manufacturers must submit standardized device information and maintain data accuracy throughout the product lifecycle.

Support Electronic Data Submission

Both systems support electronic submission methods for managing larger product portfolios.

Key Differences Between EUDAMED and FDA GUDID

Regulatory Scope

This is the biggest difference.

FDA GUDID is primarily a device identification database.

EUDAMED is a comprehensive regulatory ecosystem covering registration, certificates, clinical investigations, vigilance, and market surveillance in addition to UDI.

Type of Information Managed

GUDID focuses on:

• Device Identifier (DI)
• Label information
• Company information
• Device characteristics

EUDAMED additionally manages:

• Economic operators
• Basic UDI-DI relationships
• Certificates
• Clinical investigations
• Vigilance activities
• Market surveillance information

Regulatory Objectives

FDA GUDID supports compliance with the FDA’s Unique Device Identification Rule and serves as the reference catalog for devices marketed in the United States.

EUDAMED is intended to improve transparency, coordination between EU Member States, and oversight across the complete medical device lifecycle.

Submission Methods

For GUDID, manufacturers can submit data through:

• Manual web application
• HL7 SPL electronic submissions via the FDA Electronic Submissions Gateway

For EUDAMED, manufacturers can use:

• Manual data entry
• XML bulk uploads
• Machine-to-Machine (M2M) integration

Global Applicability

Companies marketing devices globally often need to maintain compliance with both systems.

While many core product attributes overlap, each database has unique data requirements, validation rules, and submission workflows.

Why Managing Both Systems Can Be Challenging

Organizations marketing devices in both the EU and U.S. commonly face challenges such as:

• Duplicate regulatory data
• Multiple submission formats
• Different validation rules
• Region-specific regulatory requirements
• Product lifecycle updates across multiple databases
• Manual spreadsheet management

Without centralized governance, maintaining consistency across regulatory systems becomes increasingly difficult.

How Modern UDI Software Simplifies Global Compliance

Modern UDI platforms help manufacturers manage regulatory data across multiple jurisdictions from a single source of truth.

Key capabilities include:

• Centralized Master Data Management (MDM)
• Automated regulatory validation
• XML generation
• Machine-to-Machine (M2M) integration
• Workflow automation
• Audit-ready change management
• Multi-country UDI support
• Integration with ERP, PLM, Labeling, and Regulatory Information Management (RIM) systems

By maintaining one authoritative dataset, manufacturers can generate market-specific submissions while reducing manual effort and improving data quality.

Frequently Asked Questions

Is EUDAMED the same as FDA GUDID?

No. FDA GUDID is focused on UDI device identification for the U.S. market, whereas EUDAMED is a broader regulatory platform supporting UDI registration along with certificates, vigilance, clinical investigations, and market surveillance.

Does FDA GUDID contain production identifiers?

No. GUDID stores the Device Identifier (DI) and related device information but does not store Production Identifier (PI) values such as lot or serial numbers.

Can manufacturers reuse data across both systems?

Yes. Many core product attributes overlap, but each database has its own submission requirements, validation rules, and regulatory fields, so separate submissions and system-specific compliance are still required.

What is the best approach for global UDI compliance?

The most efficient approach is to implement a centralized UDI platform that manages product master data, validates regulatory information, automates submissions, and supports multiple global regulatory databases from one source of truth.

Conclusion

Although EUDAMED and FDA GUDID both support Unique Device Identification, they serve different regulatory purposes and require distinct compliance processes. EUDAMED provides a comprehensive regulatory ecosystem for the European Union, while FDA GUDID focuses on UDI device identification for the U.S. market. Manufacturers operating internationally should adopt a centralized strategy that enables consistent product data management, automated validation, and efficient submissions across both systems.

Looking to simplify EU UDI compliance? Explore Visu UDI EUDAMED Software & Consulting Solutions to streamline EUDAMED readiness with centralized regulatory data management, automated validation, XML generation, Machine-to-Machine (M2M) integration, and expert consulting for EU MDR compliance.